CINECA IRIS Institutional Research Information System

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostra risultati da 80 a 99 di 158
Titolo Data di pubblicazione Autore(i) File
Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation 1-gen-2011 Barosi, G; Bosi, A; Abbracchio, Mp; Danesi, Romano; Genazzani, A; Corradini, P; Pane, F; Tura,
Lenograstim and filgrastim effects on neutrophil polarization after mobilization in patients undergoing A-PSCT: evaluation by computer assisted image analysis 1-gen-2003 Azzara', Antonio; Chimenti, M; Carulli, Giovanni; Fazzi, R; Galimberti, Sara; Cecconi, N; Cervetti, G; Petrini, Mario
Lithium and acute lymphocytic leukemia. 1-gen-1983 Carulli, Giovanni; Azzara', Antonio; Caracciolo, F; Margelli, M; Ambrogi, F; Grassi, B.
LONG-TERM FOLLOW-UP AND SAFETY OF DASATINIB IN CML/ALL PH1+ IMATINIB RESISTANT PATIENTS IN A COMPASSIONATE USE PROGRAM 1-gen-2009 Gozzini, A; Stagno, F; Rege Cambrin, G; Luciano, L; Breccia, M; Abruzzese, E; Martinelli, G; Orlandi, E; Gobbi, M; Pregno, P; Sica, S; Pungolino, E; Angelucci, E; Musso, M; Bruno, B; Galimberti, Sara; Nieddu, N; Specchia, G; Kropp, Mg; Annunziata, M; Musto, P; Cervellera, M; Carella, Am; Pini, M; Radaelli, F; Meneghini, F; Russo, D; Montefusco, E; Marasca, R; Gaidano, G.
LOW RPS14 EXPRESSION NEGATIVELY CONDITIONS THE PROGNOSIS OF PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES WITHOUT 5q- DURING AZACITIDINE TREATMENT. 1-gen-2012 Galimberti, Sara; Rocco, M; Grassi, S; Guerrini, F; Cervetti, G; Cecconi, N; Azzarà, A; Petrini, Mario
Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study. 1-gen-1991 Petrini, Mario; Caracciolo, F; Corini, M; Valentini, P; Sabbatini, ANTONIETTA RAFFAELLA MARIA; Grassi, B.
Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis 1-gen-2003 Nagy, B; Ferrer, A; Larramendy, Ml; Galimberti, Sara; Aalto, Y; Casas, S; Vilpo, J; Ruutu, T; Vettenranta, K; Franssila, K; Knuutila, S.
Mediterranean Diet Phytochemicals Inhibit Endothelial Activation Through Interference With Redox-Sensitive Transcriptional Factors 1-gen-2002 Carluccio, M. A.; Siculella, L; Ancora, Ma; Massaro, M; Scoditti, E; Visioli, F; Distante, Alessandro; Storelli, C; DE CATERINA, R.
MESENCHYMAL CELLS INHIBIT IL2 AND ZOLENDRONATE-INDUCED ?/d T-LYMPHOCYTES 1-gen-2007 Fazzi, R; Pacini, S; Petrini, Iacopo; Galimberti, Sara; Trombi, L; Ciabatti, E; Petrini, Mario
Missense mutations in the PML-RAR alpha ligand binding domain in ATRA resistant Arsenic trioxide sensitive relapsed acute promyelocytic leukemia 1-gen-1999 Marasca, R; Zucchini, P; Galimberti, Sara; Leonardi, G; Vaccari, P; Donelli, A; Luppi, M; Petrini, Mario; Torelli, G.
Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. 1-gen-1999 Marasca, R; Zucchini, P; Galimberti, Sara; Leonardi, G; Vaccari, P; Donelli, A; Luppi, M; Petrini, Mario; Torelli, G.
Moderately differentiated lymphocytic lymphoma mainly with bone involvement 1-gen-1985 Spremolla, G.; Ruocco, L.; Azzara', Antonio; Papineschi, Federico
Modulation of glycoprotein P in the primary culture of rat hepatocytes 1-gen-1994 Sabbatini, ANTONIETTA RAFFAELLA MARIA; Mattii, Letizia; Valentini, P; Petrini, Mario; Santoni Rugiu, E; Cervelli, F; Romiti, Nadia; Paolicchi, Aldo; Chieli, Elisabetta
Morphological analysis of phenotype MDR cell expression: morphofunctional correlations 1-gen-1994 Galimberti, Sara; Bianchi, Francesco; Bernardini, Nunzia; Mattii, Letizia; Dolfi, Amelio; Lupetti, Mario; Petrini, Mario
Morphological features following G-CSF treatment. 1-gen-1997 Azzarà, A; Carulli, Giovanni
Morphological features of rhG-CSF-induced neutrophils 1-gen-1997 Azzara', Antonio; Carulli, Giovanni
MRI SURVEY IN TRANSFUSION-DEPENDENT AND NON-TRANSFUSION DEPENDENT MDS PATIENTS 1-gen-2014 Pepe, A; Meloni, A; Carulli, Giovanni; Oliva, En; Arcioni, F; Fraticelli, V; Toia, P; Renne, S; Restaino, G; Positano, V; Rizzo, M.
Multidisciplinary Evaluation at Baseline and During Treatment Improves the Rate of Compliance and Efficacy of Deferasirox in Elderly Myelodysplastic Patients 1-gen-2016 Del Corso, L; Parodi, E.; Bardi, N; Bellodi, A.; Berisso, G.; Brunofranco, M.; Calzamiglia, T.; Di Grazia, C.; Filiberti, R.; Ghio, R; Galimberti, Sara; Molinari, E.; Russo, R.; Rousseau, M.; Scudelletti, M.; Tassara, R.; Van Lint, Mt; Arboscello, E.
Multidrug resistance : focus in hematology 1-gen-1990 Carulli, Giovanni; Petrini, Mario
Multidrug resistance in acute myeloid leukemia: significance of MDR1, BCRP, WT1 genes quantitative expression and of FLT3-ITD 1-gen-2002 Galimberti, Sara; Guerrini, F; Azzara', Antonio; Testi, R; Cervetti, G; Morabito, F; Vincelli, I; Cuzzocrea, A; Palumbo, Ga; DI RAIMONDO, F; Consoli, U; Petrini, Mario
Mostra risultati da 80 a 99 di 158
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile